Fri12192014

Last update 06:31:18 AM EST

Janssen Licenses Halozyme's Enhanze Technology

Janssen Licenses Halozyme's Enhanze Technology

Johnson & Johnson has entered into a deal ...

FDA Approves Ipsen's Somatuline Depot for Rare Tumors

FDA Approves Ipsen's Somatuline Depot for Rare Tumors

Ipsen Biopharmaceuticals, Inc.’s oncology drug S...

Neovacs' Lead Candidate Fails its Rheumatoid Arthritis Trial

Neovacs' Lead Candidate Fails its Rheumatoid Arthritis Trial

Paris-based Neovacs recently announced that its ...

CSL Submits BLA for its Investigational Hemophilia B Candidate

CSL Submits BLA for its Investigational Hemophilia B Candidate

CSL Behring recently announced that it has sub...

Novartis' Signifor LAR Approved for Treatment of Acromegaly

Novartis' Signifor LAR Approved for Treatment of Acromegaly

Novartis’ Signifor was granted approval by the...

FDA Expands Approval of Lilly's Cyramza for Lung Cancer

FDA Expands Approval of Lilly's Cyramza for Lung Cancer

The US Food and Drug Administration (FDA) has ex...

Pfizer Enters Growth Hormone Deal with Opko Health

Pfizer Enters Growth Hormone Deal with Opko Health

Today, Pfizer announced that it is partnering with Miami-based Opko Health to ...

Novartis' Psoriasis Drug Beats Out J&J's Stelara in a Late-Stage Study

Novartis' Psoriasis Drug Beats Out J&J's Stelara in a Late-Stage Study

Novartis recently announced that its psoriasis drug demonstrated superiority...

CMS Study Evaluates Access to Preferred Pharmacies

CMS Study Evaluates Access to Preferred Pharmacies

On Tuesday, officials from the Centers for Medicare and Medicaid Services (CMS...

Roche Agrees to Acquire Dutalys

Roche Agrees to Acquire Dutalys

Today, Roche announced that it has agreed to acquire privately-held biotechnol...

Merck Strengthens its Oncology Business with its Acquisition of OncoEthix

Merck Strengthens its Oncology Business with its Acquisition of OncoEthix


Today, Merck announced that it has expanded its oncology portfolio through the a...

Janssen Licenses Halozyme's Enhanze Technology

Janssen Licenses Halozyme's Enhanze Technology

Johnson & Johnson has entered into a deal to use Halozyme Therapeutics’ ...

Walgreens CEO Greg Wasson to Retire After Alliance Boots Merger

Walgreens CEO Greg Wasson to Retire After Alliance Boots Merger


DEERFIELD, Ill., December 10, 2014 - Walgreens (NYSE: WAG) (Nasdaq: WAG) today...

CSL Submits BLA for its Investigational Hemophilia B Candidate

CSL Submits BLA for its Investigational Hemophilia B Candidate

CSL Behring recently announced that it has submitted a biologics license app...

Pfizer Starts Phase II Duchenne Muscular Dystrophy Trial

Pfizer Starts Phase II Duchenne Muscular Dystrophy Trial

Pfizer recently announced that it has initiated a mid-stage study evaluating i...

Novartis' Signifor LAR Approved for Treatment of Acromegaly

Novartis' Signifor LAR Approved for Treatment of Acromegaly

Novartis’ Signifor was granted approval by the US Food and Drug Administrati...

AstraZeneca's Ovarian Cancer Drug Receives EU Approval

AstraZeneca's Ovarian Cancer Drug Receives EU Approval

AstraZeneca recently announced that the European Commission (EC) granted marke...

FDA Approves Ipsen's Somatuline Depot for Rare Tumors

FDA Approves Ipsen's Somatuline Depot for Rare Tumors

Ipsen Biopharmaceuticals, Inc.’s oncology drug Somatuline Depot (lanreotide) i...

FDA Expands Approval of Lilly's Cyramza for Lung Cancer

FDA Expands Approval of Lilly's Cyramza for Lung Cancer

The US Food and Drug Administration (FDA) has expanded approval of Eli Lilly’s...

Genentech Submits NDA for its Skin Cancer Combo

Genentech Submits NDA for its Skin Cancer Combo

Today, Roche’s Genetech announced that it has submitted a New Drug Applicati...

FDA Approves Merck's Gardasil 9

FDA Approves Merck's Gardasil 9


The U.S. Food and Drug Administration today approved Gardasil 9 (Human Papilloma...

Neovacs' Lead Candidate Fails its Rheumatoid Arthritis Trial

Neovacs' Lead Candidate Fails its Rheumatoid Arthritis Trial

Paris-based Neovacs recently announced that its rheumatoid arthritis (RA) cand...